Retaglutide is a innovative GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://sashahknk770707.pointblog.net/retaglutide-a-promising-glp-1-receptor-agonist-88002811